Jos Kitzen
Impact in
- Oncology top 10%
- Cancer survivorship and care
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cancer Treatment and Pharmacology
-
- Natural Compounds in Disease Treatment
Papers in
- Oncology 10
- HER2/EGFR in Cancer Research 5
- Peptidase Inhibition and Analysis 3
- Cancer Treatment and Pharmacology 3
- Cancer survivorship and care 2
-
- Chemotherapy-induced cardiotoxicity and mitigation 5
- Co-authors
- Jaap Verweij (11 shared papers)Maja J.A. de Jonge (3 shared papers)Monique H. W. Frings‐Dresen (3 shared papers)Monique M.E.M. Bos (3 shared papers)Sietske J. Tamminga (3 shared papers)Guus Fons (3 shared papers)Jos Verbeek (3 shared papers)Peter W. Plaisier (3 shared papers)
- Journals
- European Journal of Cancer (4 papers)Journal of Occupational Rehabilitation (2 papers)Cancer Biology & Therapy (2 papers)Breast Cancer Research and Treatment (2 papers)The Oncologist (2 papers)
- Partner nations
- NetherlandsFinlandSwitzerland
In The Last Decade
Jos Kitzen
24 papers receiving 622 citations
Peers
Comparison fields: 5 of 71
- Oncology 252
- Complementary and alternative medicine 63
- Pharmacology 70
- Cell Biology 61
- Cardiology and Cardiovascular Medicine 56
Countries citing papers authored by Jos Kitzen
This map shows the geographic impact of Jos Kitzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jos Kitzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jos Kitzen more than expected).
Fields of papers citing papers by Jos Kitzen
This network shows the impact of papers produced by Jos Kitzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jos Kitzen. The network helps show where Jos Kitzen may publish in the future.
Co-authors
The 25 scholars most cited alongside Jos Kitzen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 83 | |
| 2 | 2009 | 78 | |
| 3 | 2013 | 67 | |
| 4 | 2007 | 65 | |
| 5 | 2007 | 52 | |
| 6 | 2012 | 38 | |
| 7 | 2009 | 33 | |
| 8 | 2020 | 33 | |
| 9 | 2007 | 22 | |
| 10 | 2017 | 22 | |
| 11 | 2021 | 21 | |
| 12 | 2011 | 18 | |
| 13 | 2006 | 16 | |
| 14 | 2019 | 16 | |
| 15 | 2019 | 16 | |
| 16 | 2022 | 11 | |
| 17 | 2019 | 9 | |
| 18 | 2021 | 7 | |
| 19 | 2009 | 7 | |
| 20 | 2005 | 7 |
About Jos Kitzen
Jos Kitzen is a scholar working on Oncology, Cardiology and Cardiovascular Medicine, Molecular Biology, Pediatrics, Perinatology and Child Health and Pharmacology, having authored 25 papers that have together received 638 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (5 papers), HER2/EGFR in Cancer Research (5 papers), Peptidase Inhibition and Analysis (3 papers), Cancer Treatment and Pharmacology (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Cancer therapeutics and mechanisms (2 papers), Cancer survivorship and care (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Oncology (252 citations), Complementary and alternative medicine (63 citations), Pharmacology (70 citations), Cell Biology (61 citations) and Cardiology and Cardiovascular Medicine (56 citations). Jos Kitzen has collaborated with scholars based in Netherlands, Finland and Switzerland. Frequent co-authors include Jaap Verweij, Maja J.A. de Jonge, Monique H. W. Frings‐Dresen, Monique M.E.M. Bos, Sietske J. Tamminga, Guus Fons, Jos Verbeek, Peter W. Plaisier, Walter J. Loos and Angela G. E. M. de Boer. Their work appears in journals such as European Journal of Cancer, Journal of Occupational Rehabilitation, Cancer Biology & Therapy, Breast Cancer Research and Treatment and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.